• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC. VITEK 2 REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC. VITEK 2 REAGENT Back to Search Results
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A journal article from indonesia, "antifungal susceptibility testing in hiv/aids patients: a comparison between automated machine and manual method." was reviewed by biomérieux.The article indicated false susceptible results for voriconazole in association with vitek® 2 ast test kit(s).Test kit type(s) was not included in the article.There is no indication in the article, or any report from the laboratory associated with the article, that the discrepant result led to any adverse event related to a patient's state of health.An internal biomérieux investigation will be initiated.However, the strains use for testing are no longer available.
 
Manufacturer Narrative
A journal article from (b)(6), "antifungal susceptibility testing in (b)(6) patients: a comparison between automated machine and manual method." was reviewed by r&d.The article indicated false susceptible results for ampicillin and voriconazole in association with vitek® 2 ast test kit(s).Test kit type(s) was not included in the article.Further evaluation was requested.Strains, lab reports, product and lot numbers have been requested but are not available for investigation.Submittal of the isolate is required in order to confirm a vitek 2 discrepancy compared to reference method.Note that vitek 2 antifungals were developed compared to bmd.The reference method used in the study was clsi disk diffusion.Reported issue cannot be further investigated.Note: it was reported that this study was performed with vitek software version 04.01, suggesting the research was performed well before the 2016 publication date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK 2 REAGENT
Type of Device
VITEK 2 REAGENT
Manufacturer (Section D)
BIOMERIEUX, INC.
595 anglum road
hazelwood MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC.
595 anglum road
hazelwood MO 63042
Manufacturer Contact
tiffany hall
100 rodolphe street
durham, NC 27712
MDR Report Key7635002
MDR Text Key112758340
Report Number1950204-2018-00235
Device Sequence Number1
Product Code NGZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092454
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/25/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received08/14/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-